Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 35364210.
- Also identified by DOI 10.1016/j.jacc.2022.03.346 and PMC identifier 8961313.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.
Medical subject headings
- COVID-19
- Extracorporeal Membrane Oxygenation
- Myocarditis